İnovasyon ve fikri mülkiyet · 05.10.20201 dk okuma
Grant of Interim Extension of the Term of U.S. Patent No. 6,406,699; ECI® (ELIAS Cancer Immunotherapy)
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 6,406,699 ('699 patent).